0001209191-19-010177.txt : 20190214 0001209191-19-010177.hdr.sgml : 20190214 20190214163305 ACCESSION NUMBER: 0001209191-19-010177 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tilton John CENTRAL INDEX KEY: 0001704251 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 19607152 MAIL ADDRESS: STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP STREET 2: 234 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2018-12-31 0 0 1 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001704251 Tilton John C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 0 1 0 0 Chief Commercial Officer Stock Option (Right to Buy) 32.42 2018-11-20 4 A 0 L 30000 0.00 A 2028-11-19 Common Shares 30000 30000 D The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service with the issuer at each vesting date. /s/ Darren DeStefano, Attorney-in-Fact 2019-02-14